| Factor Information | |
|---|---|
| Data ID | 73 |
| Factor | severe neonatal morbidity and mortality |
| Description | Overall, infants born to women with all subtypes of ACHD had significantly higher odds of severe neonatal morbidity (aOR, 1.8; 95%CI,1.6-2.1) compared with infants born to women in the general population, occurring in 11.4% |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | non-preterm birth (<37 weeks) |
| p Value | <0.05 |
| OR | 1.8 |
| Conclusion | Certain ACHD subtypes may be associated with increased odds of adverse maternal and neonatal outcomes. It appears from our study that these subtypes should be monitored closely during pregnancy, and prenatal counseling provided to address these risks and any mitigation strategies. |
| Risk Factor | risk factor |
| CHD Type | |
|---|---|
| ID | 0 |
| CHD Type | |
| CHD Subtype | |
| Reference | |
|---|---|
| PMID | 31074818 |
| Year | 2019 |
| Title | Association of Adult Congenital Heart Disease With Pregnancy, Maternal, and Neonatal Outcomes. |
| Sample | ||
|---|---|---|
| Population | Adults (women) | |
| Source | Discharge Abstract Database | |
| Region | all hospitalizations in Canada (except Quebec), Canada | |
| Method | cross-sectional study | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | all infants of women withany type of ACHD(Treatment) | all infants of women without ACHD(Control) |
| Number | 241(total:2114) | 140307(total:2682451) |
| Age | 29.4±5.7 (M±SD) | 29.8±5.6 (M±SD) |
| Gender (Male: Female) | 0:24 | 0:14307 |
| Marker Level | 0.114 | 0.052 |
